Veracyte, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	139.1M	140.6M	131.9M	130.2M	114.5M	118.6M	115.9M	114.4M
Cost of Goods Sold	38.5M	36.0M	40.6M	40.4M	35.0M	39.9M	36.9M	36.5M
Gross Profit	100.6M	104.7M	91.3M	89.8M	79.5M	78.8M	79.0M	77.9M
R&D Expenses	27.1M	20.8M	16.0M	16.3M	17.7M	19.3M	17.6M	16.5M
Operating Expenses	76.7M	78.7M	68.3M	95.0M	76.6M	74.6M	67.0M	73.3M
Operating Income	23.8M	25.9M	22.9M	-5.3M	2.9M	4.2M	12.0M	4.6M
Other Income / Gains	6.1M	14.7M	-4.1M	6.5M	4.5M	-732K	4.8M	2.8M
Net Income	28.7M	41.1M	19.1M	-980K	7.0M	5.1M	15.2M	5.7M
EPS (Diluted)	0.36	0.52	0.24	-0.013	0.09	0.07	0.20	0.07
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.723	0.744	0.692	0.69	0.695	0.664	0.682	0.681
General And Administrative Expenses	23.7M	1.4M	43.2M	13.8M	52.3M	47.1M	40.5M	47.0M
Selling And Marketing Expenses	27.2M	42.9M	7.5M	43.0M	6.8M	7.7M	6.8M	7.1M
Selling General And Administrative Expenses	50.8M	44.3M	50.7M	56.7M	59.2M	54.8M	47.2M	54.1M
Other Expenses	-1.2M	13.6M	1.6M	22.0M	-277K	482K	2.2M	2.7M
Cost And Expenses	115.2M	114.7M	108.9M	135.4M	111.6M	114.5M	103.8M	109.8M
Interest Income	3.5M	0	3.5M	2.9M	2.8M	2.9M	2.9M	2.7M
Interest Expense	0	0	0	0	0	0	1K	1K
Depreciation And Amortization	5.4M	5.3M	5.3M	5.5M	5.4M	6.3M	5.9M	5.7M
Ebitda	29.3M	45.9M	24.2M	6.7M	6.5M	9.7M	22.7M	13.1M
Ebitdaratio	0.211	0.327	0.183	0.052	0.057	0.082	0.196	0.114
Operating Income Ratio	0.171	0.184	0.174	-0.04	0.025	0.035	0.104	0.04
Income Before Tax	30.0M	40.6M	18.9M	1.3M	7.4M	3.4M	16.8M	7.4M
Income Before Tax Ratio	0.216	0.289	0.143	0.01	0.065	0.029	0.145	0.064
Income Tax Expense	1.3M	-515K	-248K	2.2M	381K	-1.7M	1.7M	1.6M
Net Income Ratio	0.206	0.293	0.145	-0.008	0.062	0.043	0.131	0.05
Epsdiluted	0.35	0.50	0.24	-0.013	0.088	0.06	0.19	0.07
Weighted Average Shs Out	79.5M	79.2M	78.7M	78.2M	78.0M	77.6M	77.0M	76.5M
Weighted Average Shs Out Dil	81.3M	81.4M	79.7M	79.9M	80.1M	79.9M	78.5M	77.2M